BiotechTube
Home/92Bio/Ben Buelow, MD, PhD
BB

Ben Buelow, MD, PhD

Chief Executive Officer

92Bio

Therapeutic Areas

Oncology

92Bio Pipeline

DrugIndicationPhase
NTB-928Solid Tumors (FRα+)Pre-clinical
CD123 x γδ T-cell EngagerAcute Myeloid Leukemia (AML)Pre-clinical

Leadership Team at 92Bio

SI
Suhasini Iyer, PhD
Chief Development Officer
AB
Antara Banerjee, PhD
VP, Discovery Biology
AB
Andrew Boudreau
VP, Informatics
PK
Patrick Koenig, PhD
VP, Biologics
AP
Ashwin Patel, PhD
VP, Clinical Operations
View full 92Bio profile